Company intelligence
CardiaTec Bio
Decoding cardiovascular disease biology for novel therapeutic discovery
Biotechnology Research
Cambridge, GB
17 employees
Founded 2021
1 public signals
About CardiaTec Bio
CardiaTec harnesses human heart multiomics data and computational modelling to develop first-in-class cardiovascular therapies. Powered by a global network of 65 hospitals, the company is developing the largest proprietary human cardiac multiomics dataset, enriched with clinical annotations to unlock novel insights into disease biology. With experts from leading organisations such as Bristol Myers Squibb, AbbVie, and Recursion, CardiaTec is redefining the discovery and development of precision cardiovascular therapies.
Verified activity
Signals from CardiaTec Bio
1 published signal